Applied Mat’s Earnings Outlook

Applied Mat (NASDAQ:AMAT) is set to give its latest quarterly earnings report on Thursday, 2023-05-18. Here’s what investors…

Applied Mat (NASDAQ:AMAT) is set to give its latest quarterly earnings report on Thursday, 2023-05-18. Here’s what investors need to know before the announcement.

Analysts estimate that Applied Mat will report an earnings per share (EPS) of $1.84.

Applied Mat bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.10, which was followed by a 0.04% increase in the share price the next day.

Here’s a look at Applied Mat’s past performance and the resulting price change:

Quarter Q1 2023 Q4 2022 Q3 2022 Q2 2022
EPS Estimate 1.93 1.74 1.79 1.90
EPS Actual 2.03 2.03 1.94 1.85
Price Change % 0.04% 0.24% -3.36% -3.86%

eps graph

Stock Performance

Shares of Applied Mat were trading at $120.92 as of May 16. Over the last 52-week period, shares are up 10.67%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Applied Mat visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Earnings Outlook For Lakeland Bancorp

Lakeland Bancorp (NASDAQ:LBAI) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Lakeland Bancorp will report an earnings per share (EPS) of $0.43.

LBAI

Read More

FibroGen Shares Climb On Strong Q1 Sales

FibroGen reported quarterly losses of 33 cents per share which missed the analyst consensus estimate of $(0.31) and represents a 59.26% increase year-over-year. Quarterly sales clocked in at $55.902 million which beat the analyst consensus estimate of $36.666 million by 52.46% and is a significant increase over sales of $36.161 million from the same period last year.

FGEN